• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痕量胺相关受体 1 激动剂 RO5263397 对小鼠感觉门控的影响。

Effect of trace amine-associated receptor 1 agonist RO5263397 on sensory gating in mice.

机构信息

aDepartment of Higher Nervous Activity and Psychophysiology, Saint Petersburg State University bDepartment of General Physiology, Saint Petersburg State University cInstitute of Translational Biomedicine and Saint Petersburg University Hospital, Saint Petersburg State University, St Petersburg, Russia.

出版信息

Neuroreport. 2019 Oct 16;30(15):1004-1007. doi: 10.1097/WNR.0000000000001313.

DOI:10.1097/WNR.0000000000001313
PMID:31503202
Abstract

The trace amine-associated receptor 1 (TAAR1) agonist RO5263397 effect on sensory gating in C57BL/6 mice was studied. Sensory gating is a mechanism for dosing and filtering the incoming information, by which the brain regulates the responses to sensory stimuli coming from the environment. Sensory gating deficit is considered to be one of the schizophrenia endophenotypes. TAAR1 agonist at a 1 mg/kg dosage contributed to the sensory gating index (S1-S2) increase. Sensory gating index rose due to the N40 amplitude increase in response to the first stimulus in a pair, whereas the amplitude of the second stimulus remained unchanged. These results suggest that the sensory gating in mice may be modulated through TAAR1-dependent processes, indicating potential contribution of TAAR1 and trace amines in general to the neuropharmacology of cognitive processes.

摘要

研究了痕量胺相关受体 1(TAAR1)激动剂 RO5263397 对 C57BL/6 小鼠感觉门控的影响。感觉门控是一种调节大脑对外界环境传入信息反应的机制,通过该机制大脑可以调节对感觉刺激的反应。感觉门控缺陷被认为是精神分裂症的一种表型。1 毫克/千克剂量的 TAAR1 激动剂有助于增加感觉门控指数(S1-S2)。感觉门控指数的升高是由于对一对刺激中的第一个刺激的 N40 振幅增加,而第二个刺激的振幅保持不变。这些结果表明,小鼠的感觉门控可能通过 TAAR1 依赖的过程进行调节,表明 TAAR1 和痕量胺一般对认知过程的神经药理学有潜在贡献。

相似文献

1
Effect of trace amine-associated receptor 1 agonist RO5263397 on sensory gating in mice.痕量胺相关受体 1 激动剂 RO5263397 对小鼠感觉门控的影响。
Neuroreport. 2019 Oct 16;30(15):1004-1007. doi: 10.1097/WNR.0000000000001313.
2
TAAR5 receptor agonist affects sensory gating in rats.TAAR5受体激动剂影响大鼠的感觉门控。
Neurosci Lett. 2018 Feb 14;666:144-147. doi: 10.1016/j.neulet.2017.12.053. Epub 2017 Dec 27.
3
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight.精神分裂症的新视角:TAAR1 激动剂显示出抗精神病和抗抑郁样活性,改善认知功能并控制体重。
Mol Psychiatry. 2013 May;18(5):543-56. doi: 10.1038/mp.2012.57. Epub 2012 May 29.
4
Effect of alpha-NETA on auditory event related potentials in sensory gating study paradigm in mice.alpha-NETA 对小鼠感觉门控研究范式中听觉事件相关电位的影响。
Neurosci Lett. 2019 Nov 1;712:134470. doi: 10.1016/j.neulet.2019.134470. Epub 2019 Aug 30.
5
Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques.痕胺相关受体 1 激动剂促进清醒而不损害食蟹猴的认知能力。
Neuropsychopharmacology. 2019 Jul;44(8):1485-1493. doi: 10.1038/s41386-019-0386-8. Epub 2019 Apr 6.
6
Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice.痕量胺相关受体1激动剂调节小鼠中类似失配负波的反应。
Front Pharmacol. 2019 May 3;10:470. doi: 10.3389/fphar.2019.00470. eCollection 2019.
7
The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats.TAAR1 激动剂 RO5263397 对大鼠执行功能的作用。
Cell Mol Neurobiol. 2020 Mar;40(2):215-228. doi: 10.1007/s10571-019-00757-6. Epub 2019 Nov 16.
8
Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics.追踪与胺相关的受体 1 激动剂作为嗜睡症的治疗药物。
Biol Psychiatry. 2017 Nov 1;82(9):623-633. doi: 10.1016/j.biopsych.2016.10.012. Epub 2016 Oct 18.
9
Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats.痕量胺相关受体 1 的激活可减轻大鼠的习惯性多饮。
Neuropharmacology. 2019 Jan;144:184-192. doi: 10.1016/j.neuropharm.2018.10.034. Epub 2018 Oct 24.
10
Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.抗精神病药物对首发未用药精神分裂症患者P50感觉门控的影响。
Schizophr Res. 2009 Mar;108(1-3):151-7. doi: 10.1016/j.schres.2008.11.016. Epub 2008 Dec 23.

引用本文的文献

1
TAAR1 as an emerging target for the treatment of psychiatric disorders.TAAR1作为治疗精神疾病的一个新兴靶点。
Pharmacol Ther. 2024 Jan;253:108580. doi: 10.1016/j.pharmthera.2023.108580. Epub 2023 Dec 22.
2
Up-regulation of the Trace Amine Receptor, TAAR-1, in the Prefrontal Cortex of Individuals Affected by Schizophrenia.精神分裂症患者前额叶皮质中微量胺相关受体 1 的上调。
Schizophr Bull. 2024 Mar 7;50(2):374-381. doi: 10.1093/schbul/sbad148.
3
Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders.
释放乌洛托品作为痕量胺相关受体1激动剂对神经精神疾病的治疗潜力。
Biomedicines. 2023 Jul 13;11(7):1977. doi: 10.3390/biomedicines11071977.
4
Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions.追踪胺相关受体 1 作为开发新型抗精神病药物的靶点:研究现状和未来方向。
CNS Drugs. 2021 Nov;35(11):1153-1161. doi: 10.1007/s40263-021-00864-3. Epub 2021 Oct 15.
5
Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?代谢物感应 G 蛋白偶联受体:癌症治疗的有前途的治疗靶点?
Cells. 2020 Oct 23;9(11):2345. doi: 10.3390/cells9112345.